Skip to main content

Table 2 Mutation frequency in the lacZ and cII genes from the nasal tissues of Muta™ mice treated with 2,5-, 2,6- and 3,5-DMAs

From: Mutagenic properties of dimethylaniline isomers in mice as evaluated by comet, micronucleus and transgenic mutation assays

Animal ID

lacZ

cII

Total plaquesa

Mutants

MF (× 106)

Mean ± SD

Total plaquesa

Mutants

MF (× 106)

Mean ± SD

Control (olive oil)

41

(36000)

5

138.9

 

(59400)

4

67.3

 

42

(13000)

2

153.8

 

(10800)

1

92.6

 

43

373,000

19

50.9

 

399,600

10

25.0

 

44

306,000

9

29.4

 

321,000

5

15.6

 

45

477,500

14

29.3

 

396,600

7

17.7

 

Total

1,205,500

49

40.6

36.6 ± 10.2

1,187,400

27

22.7

19.4 ± 4.1

2,5-DMA

81

471,000

40

84.9

 

546,000

41

75.1

 

82

821,000

71

86.5

 

871,200

40

45.9

 

83

388,500

42

108.1

 

639,600

28

43.8

 

84

731,000

70

95.8

 

916,800

32

34.9

 

85

566,500

40

70.6

 

552,600

31

56.1

 

Total

2,978,000

263

88.3

89.2 ± 12.4 c

3,526,200

172

48.8

51.2 ± 13.7 b

2,6-DMA

91

172,500

9

52.2

 

261,000

6

23.0

 

92

260,000

26

100.0

 

429,600

13

30.3

 

93

391,000

26

66.5

 

493,200

46

93.3

 

94

(0)

0

0

 

(0)

0

0

 

95

252,000

29

115.1

 

379,200

21

55.4

 

Total

1,075,500

90

83.7

83.4 ± 25.2 b

1,563,000

86

55.0

50.5 ± 27.5

3,5-DMA

101

276,500

11

39.8

 

1,854,600

16

8.6

 

102

554,500

49

88.4

 

850,800

27

31.7

 

103

665,500

23

34.6

 

810,000

18

22.2

 

104

601,500

22

36.6

 

411,600

22

53.4

 

105

192,000

14

72.9

 

246,000

11

44.7

 

Total

2,290,000

119

52.0

54.4 ± 22

4,173,000

94

22.5

32.1 ± 15.9

  1. aData with at least 100,000 total plaques were evaluated by the statistical analysis and a parenthesis indicates exclusion
  2. bSignificantly different from the control (P < 0.05) by t-test
  3. cSignificantly different from the control (P < 0.01) by t-test